Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Previous issues

Page Path
HOME > Browse Articles > Previous issues
8 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 8(3); September 2015
Prev issue Next issue
Review Articles
What Is Wrong with Balance in Parkinson’s Disease?
Jeong-Ho Park, Yeo-Jeong Kang, Fay Bahling Horak
J Mov Disord. 2015;8(3):109-114.   Published online September 10, 2015
DOI: https://doi.org/10.14802/jmd.15018
  • 20,713 View
  • 342 Download
  • 58 Citations
AbstractAbstract PDF
Postural instability and resulting falls are major factors determining quality of life, morbidity, and mortality in individuals with Parkinson’s disease (PD). A better understanding of balance impairments would improve management of balance dysfunction and prevent falls in patients with PD. The effects of bradykinesia, rigidity, impaired proprioception, freezing of gait and attention on postural stability in patients with idiopathic PD have been well characterized in laboratory studies. The purpose of this review is to systematically summarize the types of balance impairments contributing to postural instability in people with PD.

Citations

Citations to this article as recorded by  
  • The influence of cognitive tasks on sensory organization test performance
    Nathan Morelli, Nicholas R. Heebner, Courtney J. DeFeo, Matthew C. Hoch
    Brazilian Journal of Otorhinolaryngology.2022; 88(6): 841.     CrossRef
  • Influence of radial optic flow stimulation on static postural balance in Parkinson's disease: A preliminary study
    Alessandro Piras, Aurelio Trofè, Andrea Meoni, Milena Raffi
    Human Movement Science.2022; 81: 102905.     CrossRef
  • The effect of Tai Chi on functional mobility, balance and falls in Parkinson's disease: A systematic review and meta-analysis of systematic reviews
    Bahar Aras, Gulce Kallem Seyyar, Oznur Fidan, Ertugrul Colak
    EXPLORE.2022; 18(4): 402.     CrossRef
  • Avaliação do risco de quedas entre pessoas com doença de Parkinson
    Franciny da Silva, Angela Maria Alvarez, Simony Fabíola Lopes Nunes, Maria Eduarda Massari Silva, Silvia Maria Azevedo Dos Santos
    Escola Anna Nery.2022;[Epub]     CrossRef
  • Acceptability and Preliminary Results of Technology-Assisted Balance Training in Parkinson’s Disease
    Elvira Maranesi, Valentina Di Donna, Giuseppe Pelliccioni, Valentina Cameriere, Elisa Casoni, Renato Baldoni, Marco Benadduci, Nadia Rinaldi, Lorenzo Fantechi, Cinzia Giammarchi, Riccardo Luzi, Paolo Pelliccioni, Mirko Di Rosa, Pietro Scendoni, Giovanni R
    International Journal of Environmental Research and Public Health.2022; 19(5): 2655.     CrossRef
  • A systematic review on the effectiveness of perturbation-based balance training in postural control and gait in Parkinson’s disease
    Daniel Boari Coelho, Claudia Eunice Neves de Oliveira, Marcos Vinicius Carvalho Guimarães, Caroline Ribeiro de Souza, Márcio Luiz dos Santos, Andrea C. de Lima-Pardini
    Physiotherapy.2022; 116: 58.     CrossRef
  • Therapeutic Implications of Caffeic Acid in Cancer and Neurological Diseases
    Manzar Alam, Sarfraz Ahmed, Abdelbaset Mohamed Elasbali, Mohd Adnan, Shoaib Alam, Md. Imtaiyaz Hassan, Visweswara Rao Pasupuleti
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Rasch Validation of the Mini-BESTest in People With Parkinson Disease
    Franco Franchignoni, Marco Godi, Stefano Corna, Andrea Giordano
    Journal of Neurologic Physical Therapy.2022; 46(3): 219.     CrossRef
  • Factors Contributing to Repeated Falls in Patients with Parkinsonʼs Disease : Focusing on Falls Self-efficacy and Cognition of Punishment
    Yasuomi Tomii, Mika Otsuki, Naoya Hasegawa
    Higher Brain Function Research.2022; 42(1): 29.     CrossRef
  • Short-Term Motor Outcomes in Parkinson’s Disease after Subthalamic Nucleus Deep Brain Stimulation Combined with Post-Operative Rehabilitation: A Pre-Post Comparison Study
    Kazunori Sato, Yoshihide Hokari, Eriko Kitahara, Nana Izawa, Kozo Hatori, Kaoru Honaga, Genko Oyama, Taku Hatano, Hirokazu Iwamuro, Atsushi Umemura, Yasushi Shimo, Nobutaka Hattori, Toshiyuki Fujiwara, Giuseppina Martella
    Parkinson's Disease.2022; 2022: 1.     CrossRef
  • Assessing perceptions to a virtual reality intervention to improve trunk control in Parkinson’s disease: a preliminary study
    Alexander Stamenkovic, Matthew Underation, Leslie J. Cloud, Peter E. Pidcoe, Mark S. Baron, Robert Hand, Christopher R. France, Susanne M. van der Veen, James S. Thomas
    Virtual Reality.2022;[Epub]     CrossRef
  • Re-conceptualizing postural control assessment in sport-related concussion: Transitioning from the reflex/hierarchical model to the systems model
    Thaer S. Manaseer, Douglas P. Gross, Martin Mrazik, Kathryn Schneider, Jackie L. Whittaker
    Physiotherapy Theory and Practice.2021; 37(7): 763.     CrossRef
  • Short-term effects of postural control by standing on a tilting board in patients with Parkinson’s disease
    Naoya Hasegawa, Keita Ishikawa, Yuki Sato, Yasuhide Nakayama, Tadayoshi Asaka
    Physiotherapy Theory and Practice.2021; 37(12): 1306.     CrossRef
  • Comparison of the effect of whole-body vibration therapy versus conventional therapy on functional balance of patients with Parkinson’s disease: adding a mixed group
    Eduardo Guadarrama-Molina, Carlos Enrique Barrón-Gámez, Ingrid Estrada-Bellmann, Jesús D. Meléndez-Flores, Paola Ramírez-Castañeda, Rosa María Gisela Hernández-Suárez, Minerva Menchaca-Pérez, Oscar Salas-Fraire
    Acta Neurologica Belgica.2021; 121(3): 721.     CrossRef
  • Impact of Physiotherapy Absence in COVID-19 Pandemic on Neurological State of Patients With Parkinson Disease
    Alen Kapel, Domen Serdoner, Ester Fabiani, Tomaz Velnar
    Topics in Geriatric Rehabilitation.2021; 37(1): 50.     CrossRef
  • The relationship between attention and static balance disturbance in patients with Parkinson’s disease
    Amir Dana, Amir Shams, Nahid Allafan, Alireza Bahrami
    Neurological Sciences.2021; 42(12): 5107.     CrossRef
  • Does the impaired postural control in Parkinson's disease affect the habituation to non-sequential external perturbation trials?
    Victor Spiandor Beretta, Mark Gregory Carpenter, Fabio Augusto Barbieri, Paulo Cezar Rocha Santos, Diego Orcioli-Silva, Marcelo Pinto Pereira, Lilian Teresa Bucken Gobbi
    Clinical Biomechanics.2021; 85: 105363.     CrossRef
  • Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson’s disease
    J. Lucas McKay, Kimberly C. Lang, Sistania M. Bong, Madeleine E. Hackney, Stewart A. Factor, Lena H. Ting, Manabu Sakakibara
    PLOS ONE.2021; 16(5): e0252119.     CrossRef
  • Establishing the Rotenone-Induced Parkinson's Disease Animal Model in Wistar Albino Rats
    Gangadhara Swamy, Rajendra Holla, Suresh R. Rao
    Journal of Health and Allied Sciences NU.2021; 11(03): 158.     CrossRef
  • Development of a Parkinson’s disease specific falls questionnaire
    Dale M. Harris, Rachel L. Duckham, Robin M. Daly, Gavin Abbott, Liam Johnson, Timo Rantalainen, Wei-Peng Teo
    BMC Geriatrics.2021;[Epub]     CrossRef
  • Correlation between community balance and mobility scale (CB&M) with a battery of outcome measures to assess balance in Parkinson’s disease – a cross-sectional study
    Ziona Lionel Dsouza, Sydney Roshan Rebello, Cherishma Dsilva
    Archives of Physiotherapy.2021;[Epub]     CrossRef
  • Cholinesterase inhibitors for gait, balance, and fall in Parkinson disease: a meta-analysis
    Jia-Hung Chen, Tsai-Wei Huang, Chien-Tai Hong
    npj Parkinson's Disease.2021;[Epub]     CrossRef
  • Dancing With Parkinson's Disease: The SI-ROBOTICS Study Protocol
    Roberta Bevilacqua, Marco Benadduci, Anna Rita Bonfigli, Giovanni Renato Riccardi, Giovanni Melone, Angela La Forgia, Nicola Macchiarulo, Luca Rossetti, Mauro Marzorati, Giovanna Rizzo, Pierpaolo Di Bitonto, Ada Potenza, Laura Fiorini, Federica Gabriella
    Frontiers in Public Health.2021;[Epub]     CrossRef
  • Balance and mobility in patients with newly diagnosed Parkinson’s disease – a five-year follow-up of a cohort in northern Sweden
    Christer Johansson, Britta Lindström, Lars Forsgren, Gudrun M. Johansson
    Disability and Rehabilitation.2020; 42(6): 770.     CrossRef
  • Minimal Detectable Change for Balance Using the Biodex Balance System in Patients with Parkinson Disease
    Jumes Leopoldino Oliveira Lira, Carlos Ugrinowitsch, Rafael Fecchio, Daniel Boari Coelho, Acácio Moreira‐Neto, Renan Germano, Angelo Corrêa Lima Miliatto, Bianca Cristina Santos Vieira Yano, Carla Silva‐Batista
    PM&R.2020; 12(3): 281.     CrossRef
  • Perception of whole-body motion during balance perturbations is impaired in Parkinson's disease and is associated with balance impairment
    Sistania M. Bong, J. Lucas McKay, Stewart A. Factor, Lena H. Ting
    Gait & Posture.2020; 76: 44.     CrossRef
  • Postural impairments in Parkinson’s disease are not associated with changes in circadian rhythms changes
    Luiz Claudio Zulai, André Martinez Albuquerque, Caluê Papcke, Fernando Mazzilli Louzada, Eduardo Mendonça Scheeren
    Chronobiology International.2020; 37(1): 135.     CrossRef
  • Choreographing life-experiences of balance control in people with Parkinson’s disease
    Sofie LaGrone, Conran Joseph, Hanna Johansson, Birgit Enberg, Erika Franzén
    BMC Neurology.2020;[Epub]     CrossRef
  • Effect of home-based Tai Chi, Yoga or conventional balance exercise on functional balance and mobility among persons with idiopathic Parkinson’s disease: An experimental study
    Arva Khuzema, A. Brammatha, V. Arul Selvan
    Hong Kong Physiotherapy Journal.2020; 40(01): 39.     CrossRef
  • A comparison of the relationship between manual dexterity and postural control in young and older individuals with Parkinson’s disease
    Aybuke Cansu Kalkan, Turhan Kahraman, Biron Onur Ugut, Berril Donmez Colakoglu, Arzu Genc
    Journal of Clinical Neuroscience.2020; 75: 89.     CrossRef
  • Explaining Parkinsonian postural sway variabilities using intermittent control theory
    Ranjita Dash, Vrutangkumar V. Shah, Harish J. Palanthandalam-Madapusi
    Journal of Biomechanics.2020; 105: 109791.     CrossRef
  • Rehabilitation of older people with Parkinson’s disease: an innovative protocol for RCT study to evaluate the potential of robotic-based technologies
    Roberta Bevilacqua, Elvira Maranesi, Mirko Di Rosa, Riccardo Luzi, Elisa Casoni, Nadia Rinaldi, Renato Baldoni, Fabrizia Lattanzio, Valentina Di Donna, Giuseppe Pelliccioni, Giovanni Renato Riccardi
    BMC Neurology.2020;[Epub]     CrossRef
  • Assessment of Functional Activities in Individuals with Parkinson’s Disease Using a Simple and Reliable Smartphone-Based Procedure
    Pilar Serra-Añó, José Francisco Pedrero-Sánchez, Marta Inglés, Marta Aguilar-Rodríguez, Ismael Vargas-Villanueva, Juan López-Pascual
    International Journal of Environmental Research and Public Health.2020; 17(11): 4123.     CrossRef
  • New insight into Parkinson’s disease‐related impairment of the automatic control of upright stance
    Cédrick T. Bonnet, Arnaud Delval, Tarkeshwar Singh, Yann‐Romain Kechabia, Luc Defebvre
    European Journal of Neuroscience.2020; 52(12): 4851.     CrossRef
  • Innovative Parkinson's Disease Patients' Motor Skills Assessment: The i-PROGNOSIS Paradigm
    Sofia Balula Dias, Athina Grammatikopoulou, José Alves Diniz, Kosmas Dimitropoulos, Nikos Grammalidis, Vicky Zilidou, Theodore Savvidis, Evdokimos Konstantinidis, Panagiotis D. Bamidis, Hagen Jaeger, Michael Stadtschnitzer, Hugo Silva, Gonçalo Telo, Ioann
    Frontiers in Computer Science.2020;[Epub]     CrossRef
  • Effects of multimodal balance training supported by rhythmical auditory stimuli in people with advanced stages of Parkinson's disease: a pilot randomized clinical trial
    Tamine T.C. Capato, Jorik Nonnekes, Nienke M. de Vries, Joanna IntHout, Egberto R. Barbosa, Bastiaan R. Bloem
    Journal of the Neurological Sciences.2020; 418: 117086.     CrossRef
  • Responsiveness of Objective vs. Clinical Balance Domain Outcomes for Exercise Intervention in Parkinson's Disease
    Naoya Hasegawa, Vrutangkumar V. Shah, Graham Harker, Patricia Carlson-Kuhta, John G. Nutt, Jodi A. Lapidus, Se Hee Jung, Nancy Barlow, Laurie A. King, Fay B. Horak, Martina Mancini
    Frontiers in Neurology.2020;[Epub]     CrossRef
  • Neuroprotective Effects of Coffee Bioactive Compounds: A Review
    Katarzyna Socała, Aleksandra Szopa, Anna Serefko, Ewa Poleszak, Piotr Wlaź
    International Journal of Molecular Sciences.2020; 22(1): 107.     CrossRef
  • Parkinson's Disease and Parkinsonism
    Michael T. Hayes
    The American Journal of Medicine.2019; 132(7): 802.     CrossRef
  • How to Select Balance Measures Sensitive to Parkinson’s Disease from Body-Worn Inertial Sensors—Separating the Trees from the Forest
    Naoya Hasegawa, Vrutangkumar V. Shah, Patricia Carlson-Kuhta, John G. Nutt, Fay B. Horak, Martina Mancini
    Sensors.2019; 19(15): 3320.     CrossRef
  • Treatment options for postural instability and gait difficulties in Parkinson’s disease
    Martijn L.T.M. Müller, Uros Marusic, Miriam van Emde Boas, Daniel Weiss, Nicolaas I. Bohnen
    Expert Review of Neurotherapeutics.2019; 19(12): 1229.     CrossRef
  • A new technique to test the effect of cognition on standing balance in Parkinson’s disease
    M Bhatt, B Mahana, JJ Marotta, JH Ko, T Szturm
    Open Journal of Parkinson's Disease and Treatment.2019; 2(1): 006.     CrossRef
  • Step length determines minimum toe clearance in older adults and people with Parkinson’s disease
    Lisa Alcock, Brook Galna, Ruth Perkins, Sue Lord, Lynn Rochester
    Journal of Biomechanics.2018; 71: 30.     CrossRef
  • Long-term effects of highly challenging balance training in Parkinson’s disease—a randomized controlled trial
    Martin Benka Wallén, Maria Hagströmer, David Conradsson, Kimmo Sorjonen, Erika Franzén
    Clinical Rehabilitation.2018; : 026921551878433.     CrossRef
  • Parkinson's disease versus ageing: different postural responses to soleus muscle vibration
    Diana Bzdúšková, Peter Valkovič, Zuzana Hirjaková, Jana Kimijanová, František Hlavačka
    Gait & Posture.2018; 65: 169.     CrossRef
  • A High-Intensity Multicomponent Agility Intervention Improves Parkinson Patients’ Clinical and Motor Symptoms
    József Tollár, Ferenc Nagy, Norbert Kovács, Tibor Hortobágyi
    Archives of Physical Medicine and Rehabilitation.2018; 99(12): 2478.     CrossRef
  • Parkinson’s disease does not alter automatic visual-motor coupling in postural control
    Caio Ferraz Cruz, Maria Elisa Pimentel Piemonte, Líria Akie Okai-Nobrega, Erika Okamoto, Ana Claudia de Souza Fortaleza, Martina Mancini, Fay Bahling Horak, José Angelo Barela
    Neuroscience Letters.2018; 686: 47.     CrossRef
  • Assessing Walking Adaptability in Parkinson's Disease: “The Interactive Walkway”
    Daphne J. Geerse, Melvyn Roerdink, Johan Marinus, Jacobus J. van Hilten
    Frontiers in Neurology.2018;[Epub]     CrossRef
  • Camptocormia with Transient Ischemic Attack
    Ju-Hee Oh, Dong-Woo Ryu, Si-Hoon Lee, Joong-Seok Kim
    Journal of Movement Disorders.2017; 10(1): 62.     CrossRef
  • Motor dysfunction and alterations in glutathione concentration, cholinesterase activity, and BDNF expression in substantia nigra pars compacta in rats with pedunculopontine lesion
    Lisette Blanco-Lezcano, Javier Jimenez-Martin, Mei-Li Díaz-Hung, Esteban Alberti-Amador, Maylin Wong-Guerra, Ma. Elena González-Fraguela, Bárbara Estupiñán-Díaz, Teresa Serrano-Sánchez, Liliana Francis-Turner, Susana Delgado-Ocaña, Yanier Núñez-Figueredo,
    Neuroscience.2017; 348: 83.     CrossRef
  • Axial rigidity is related to the risk of falls in patients with Parkinson’s disease
    Roberto Cano-de-la-Cuerda, Lydia Vela-Desojo, Juan Carlos Miangolarra-Page, Yolanda Macías-Macías
    NeuroRehabilitation.2017; 40(4): 569.     CrossRef
  • Body Posture, Postural Stability, and Metabolic Age in Patients with Parkinson’s Disease
    Jacek Wilczyński, Agnieszka Pedrycz, Dariusz Mucha, Tadeusz Ambroży, Dawid Mucha
    BioMed Research International.2017; 2017: 1.     CrossRef
  • Investigation of Anticipatory Postural Adjustments during One-Leg Stance Using Inertial Sensors: Evidence from Subjects with Parkinsonism
    Gianluca Bonora, Martina Mancini, Ilaria Carpinella, Lorenzo Chiari, Maurizio Ferrarin, John G. Nutt, Fay B. Horak
    Frontiers in Neurology.2017;[Epub]     CrossRef
  • Altered neurofilament protein expression in the lateral vestibular nucleus in Parkinson’s disease
    Thomas P. Wellings, Alan M. Brichta, Rebecca Lim
    Experimental Brain Research.2017; 235(12): 3695.     CrossRef
  • Biomechanical Analysis of Dance for Parkinson’s Disease: A Paradoxical Case Study of Balance and Gait Effects?
    Kristen L. Sowalsky, Jill Sonke, Lori J.P. Altmann, Leonardo Almeida, Chris J. Hass
    EXPLORE.2017; 13(6): 409.     CrossRef
  • Femur Fractures in Parkinsonism: Analysis of a National Sample Cohort in South Korea
    Soo Jeong An, Seung-Hwan Lee, Seo-Young Lee, Jae-Woo Kwon, Seung-Joon Lee, Young-Ju Kim
    Journal of Clinical Neurology.2017; 13(4): 380.     CrossRef
  • The International Classification of Functioning, Disability and Health as Applied to Parkinson’s Disease: A Literature Review
    Audrin Said Vojciechowski, Talita Gianello Gnoato Zotz, Ana Paula Cunha Loureiro, Vera Lúcia Israel
    Advances in Parkinson's Disease.2016; 05(02): 29.     CrossRef
  • Can Gait Signatures Provide Quantitative Measures for Aiding Clinical Decision-Making? A Systematic Meta-Analysis of Gait Variability Behavior in Patients with Parkinson's Disease
    Niklas König, Navrag B. Singh, Christian R. Baumann, William R. Taylor
    Frontiers in Human Neuroscience.2016;[Epub]     CrossRef
The Current Status of Deep Brain Stimulation for the Treatment of Parkinson Disease in the Republic of Korea
Jung-Il Lee
J Mov Disord. 2015;8(3):115-121.   Published online September 10, 2015
DOI: https://doi.org/10.14802/jmd.15043
  • 19,759 View
  • 115 Download
  • 6 Citations
AbstractAbstract PDF
Parkinson disease (PD) is a common neurodegenerative disease with an increasing prevalence in Korea. Deep brain stimulation (DBS) is a safe and effective surgical treatment option for this disease. The aim of this review was to provide an update regarding current DBS practices with respect to the treatment of PD in the Republic of Korea. The first DBS in Korea was performed in 2000; approximately 2,000 patients have undergone DBS for a variety of neurological disorders, the majority of whom were patients with PD. Approximately 150 new patients with PD receive DBS annually, and more than 20 centers perform DBS. However, DBS remains underutilized for many reasons, and the clinical case burden at many institutions is below the level presumed adequate for qualified practice. With a rapidly aging population and an evolving socioeconomic environment, the need for surgical intervention for PD is likely to increase significantly in the future. Many issues such as finances, education, and quality assurance must be resolved to cope with this need.

Citations

Citations to this article as recorded by  
  • Practice Trends of Neuromodulation Therapies for Pain and Spasticity in India
    Preeti P. Doshi, Marc Russo, Paresh K. Doshi
    Neuromodulation: Technology at the Neural Interface.2021;[Epub]     CrossRef
  • An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East
    Chencheng Zhang, Adolfo Ramirez-Zamora, Fangang Meng, Zhengyu Lin, Yijie Lai, Dianyou Li, Jinwoo Chang, Takashi Morishita, Tooru Inoue, Shinsuke Fujioka, Genko Oyama, Terry Coyne, Valerie Voon, Paresh K. Doshi, Yiwen Wu, Jun Liu, Bhavana Patel, Leonardo A
    Frontiers in Human Neuroscience.2020;[Epub]     CrossRef
  • Canadian Assessment of Deep Brain Stimulation Access: The Canada Study
    C. Michael Honey, Armaan K. Malhotra, Mandeep S. Tamber, Michel Prud’homme, Ivar Mendez, Christopher R. Honey
    Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.2018; 45(5): 553.     CrossRef
  • Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case–Control Study in South Korea
    Hae-Young Park, Ji-Won Park, Hyun Soon Sohn, Jin-Won Kwon
    Drug Safety.2017; 40(11): 1109.     CrossRef
  • La Enfermedad de Parkinson: Etiología, Tratamientos y Factores Preventivos
    F Hurtado, Melissa Andrea N Cardenas, Fernando Cardenas, Laura Andrea León
    Universitas Psychologica.2017;[Epub]     CrossRef
  • Isolated dystypia after subthalamic nucleus deep brain stimulation in a patient with Parkinson’s disease
    Si-Hoon Lee, Kipyung Jeon, Byung-chul Son, Joong-Seok Kim
    Acta Neurochirurgica.2016; 158(4): 783.     CrossRef
Genetics of Progressive Supranuclear Palsy
Sun Young Im, Young Eun Kim, Yun Joong Kim
J Mov Disord. 2015;8(3):122-129.   Published online September 10, 2015
DOI: https://doi.org/10.14802/jmd.15033
  • 25,873 View
  • 370 Download
  • 32 Citations
AbstractAbstract PDF
Progressive supranuclear palsy (PSP) is a neurodegenerative syndrome that is clinically characterized by progressive postural instability, supranuclear gaze palsy, parkinsonism and cognitive decline. Pathologically, diagnosis of PSP is based on characteristic features, such as neurofibrillary tangles, neutrophil threads, tau-positive astrocytes and their processes in basal ganglia and brainstem, and the accumulation of 4 repeat tau protein. PSP is generally recognized as a sporadic disorder; however, understanding of genetic background of PSP has been expanding rapidly. Here we review relevant publications to outline the genetics of PSP. Although only small number of familial PSP cases have been reported, the recognition of familial PSP has been increasing. In some familial cases of clinically probable PSP, PSP pathologies were confirmed based on NINDS neuropathological diagnostic criteria. Several mutations in MAPT, the gene that causes a form of familial frontotemporal lobar degeneration with tauopathy, have been identified in both sporadic and familial PSP cases. The H1 haplotype of MAPT is a risk haplotype for PSP, and within H1, a sub-haplotype (H1c) is associated with PSP. A recent genome-wide association study on autopsyproven PSP revealed additional PSP risk alleles in STX6 and EIF2AK3. Several heredodegenerative parkinsonian disorders are referred to as PSP-look-alikes because their clinical phenotype, but not their pathology, mimics PSP. Due to the fast development of genomics and bioinformatics, more genetic factors related to PSP are expected to be discovered. Undoubtedly, these studies will provide a better understanding of the pathogenesis of PSP and clues for developing therapeutic strategies.

Citations

Citations to this article as recorded by  
  • Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism
    Patrycja Krzosek, Natalia Madetko, Anna Migda, Bartosz Migda, Dominika Jaguś, Piotr Alster
    Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
  • Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT Locus
    Alexander Fröhlich, Abigail L. Pfaff, Vivien J. Bubb, Sulev Koks, John P. Quinn
    Frontiers in Molecular Neuroscience.2022;[Epub]     CrossRef
  • Case of a Man with Hemichorea and Behavioral Changes: “A Red Herring”
    Galit Kleiner, Stephen A. Ryan, Juan Bilbao, Julia Keith, Ekaterina Rogaeva, Sandra E. Black, Anthony E. Lang, Mario Masellis
    Movement Disorders Clinical Practice.2022; 9(4): 501.     CrossRef
  • MAPT gene mutation in familiar progressive supranuclear palsy, a case report
    M. Rodríguez, H. Kreinter, N. Zapa, O. Oliveros, C. Jiménez
    Neurology Perspectives.2022; 2(3): 184.     CrossRef
  • Genetic Architecture of Primary Tauopathies
    Daniel Gallo, Agustín Ruiz, Pascual Sánchez-Juan
    Neuroscience.2022;[Epub]     CrossRef
  • Investigational therapeutics for the treatment of progressive supranuclear palsy
    David G Coughlin, Irene Litvan
    Expert Opinion on Investigational Drugs.2022; 31(8): 813.     CrossRef
  • Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression
    Abigail L. Pfaff, Vivien J. Bubb, John P. Quinn, Sulev Koks
    npj Parkinson's Disease.2021;[Epub]     CrossRef
  • Cellular and pathological heterogeneity of primary tauopathies
    Dah-eun Chloe Chung, Shanu Roemer, Leonard Petrucelli, Dennis W. Dickson
    Molecular Neurodegeneration.2021;[Epub]     CrossRef
  • Tau and MAPT genetics in tauopathies and synucleinopathies
    Etienne Leveille, Owen A. Ross, Ziv Gan-Or
    Parkinsonism & Related Disorders.2021; 90: 142.     CrossRef
  • Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders
    Anne Messer, David C. Butler
    Neurobiology of Disease.2020; 134: 104619.     CrossRef
  • Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured neurons
    Carolina Alquezar, Jessica B. Felix, Elizabeth McCandlish, Brian T. Buckley, Dominique Caparros-Lefebvre, Celeste M. Karch, Lawrence I. Golbe, Aimee W. Kao
    Scientific Reports.2020;[Epub]     CrossRef
  • LRP10 variants in progressive supranuclear palsy
    Leonie J.M. Vergouw, Shamiram Melhem, Laura Donker Kaat, Wang Z. Chiu, Demy J.S. Kuipers, Guido Breedveld, Agnita J.W. Boon, Li-San Wang, Adam C. Naj, Elizabeth Mlynarksi, Laura Cantwell, Marialuisa Quadri, Owen A. Ross, Dennis W. Dickson, Gerard D. Schel
    Neurobiology of Aging.2020;[Epub]     CrossRef
  • Neuro-ophthalmology in the Geriatric Eye
    Subhan Tabba, Yi-Hsien Yeh, Ashwini Kini, Bayan Al Othman, Andrew G Lee
    US Ophthalmic Review.2020; 13(1): 30.     CrossRef
  • Genetic Risk Factors for Essential Tremor: A Review
    Vasileios Siokas, Athina-Maria Aloizou, Zisis Tsouris, Ioannis Liampas, Paraskevi Aslanidou, Metaxia Dastamani, Alexandros G. Brotis, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou, Efthimios Dardiotis
    Tremor and Other Hyperkinetic Movements.2020; 10: 4.     CrossRef
  • PSP-FTD Complex: A Possible Variant of PSP
    Sunil Pradhan, Ruchika Tandon
    American Journal of Alzheimer's Disease & Other Dementiasr.2020; 35: 153331752092238.     CrossRef
  • Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP)
    Piotr Alster, Natalia Madetko, Dariusz Koziorowski, Andrzej Friedman
    Frontiers in Neuroscience.2020;[Epub]     CrossRef
  • Tau at the interface between neurodegeneration and neuroinflammation
    Alessandro Didonna
    Genes & Immunity.2020; 21(5): 288.     CrossRef
  • Efficiency of Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy: Estimation Using Goniometry and Dinamometry
    K. A. Major, Z. Zs. Major, R. Craciunas, G. Carbone, C. Vaida, D. L. Pîslă
    Neurophysiology.2019; 51(1): 57.     CrossRef
  • Four-repeat tauopathies
    Thomas W. Rösler, Amir Tayaranian Marvian, Matthias Brendel, Niko-Petteri Nykänen, Matthias Höllerhage, Sigrid C. Schwarz, Franziska Hopfner, Thomas Koeglsperger, Gesine Respondek, Kerstin Schweyer, Johannes Levin, Victor L. Villemagne, Henryk Barthel, Os
    Progress in Neurobiology.2019; 180: 101644.     CrossRef
  • One decade ago, one decade ahead in progressive supranuclear palsy
    Maria Stamelou, Nikolaos Giagkou, Günter U Höglinger
    Movement Disorders.2019; 34(9): 1284.     CrossRef
  • The genetic and clinico‐pathological profile of early‐onset progressive supranuclear palsy
    Edwin Jabbari, John Woodside, Manuela M.X. Tan, Nicola Pavese, Oliver Bandmann, Boyd C.P. Ghosh, Luke A. Massey, Erica Capps, Tom T. Warner, Andrew J. Lees, Tamas Revesz, Janice L. Holton, Nigel M. Williams, Donald G. Grosset, Huw R. Morris
    Movement Disorders.2019; 34(9): 1307.     CrossRef
  • Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models
    Marina Sánchez, Ana García-Cabrero, Gentzane Sánchez-Elexpuru, Daniel Burgos, José Serratosa
    International Journal of Molecular Sciences.2018; 19(4): 1092.     CrossRef
  • Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci
    Monica Y. Sanchez-Contreras, Naomi Kouri, Casey N. Cook, Daniel J. Serie, Michael G. Heckman, NiCole A. Finch, Richard J. Caselli, Ryan J. Uitti, Zbigniew K. Wszolek, Neill Graff-Radford, Leonard Petrucelli, Li-San Wang, Gerard D. Schellenberg, Dennis W.
    Molecular Neurodegeneration.2018;[Epub]     CrossRef
  • Improving Mouse Models for Dementia. Are All the Effects in Tau Mouse Models Due to Overexpression?
    Zelah Joel, Pablo Izquierdo, Dervis A. Salih, Jill C. Richardson, Damian M. Cummings, Frances A. Edwards
    Cold Spring Harbor Symposia on Quantitative Biology.2018; 83: 151.     CrossRef
  • Signature of an aggregation-prone conformation of tau
    Neil A. Eschmann, Elka R. Georgieva, Pritam Ganguly, Peter P. Borbat, Maxime D. Rappaport, Yasar Akdogan, Jack H. Freed, Joan-Emma Shea, Songi Han
    Scientific Reports.2017;[Epub]     CrossRef
  • Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology
    Jacqueline R. Kulbe, Edward D. Hall
    Progress in Neurobiology.2017; 158: 15.     CrossRef
  • MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17)
    Robert Haussmann, Marek Wysocki, Moritz D. Brandt, Andreas Hermann, Markus Donix
    International Psychogeriatrics.2017; 29(5): 869.     CrossRef
  • Progressieve supranucleaire parese
    Peter van Domburg
    Neuropraxis.2016; 20(2): 68.     CrossRef
  • Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci
    Mariet Allen, Jeremy D. Burgess, Travis Ballard, Daniel Serie, Xue Wang, Curtis S. Younkin, Zhifu Sun, Naomi Kouri, Saurabh Baheti, Chen Wang, Minerva M. Carrasquillo, Thuy Nguyen, Sarah Lincoln, Kimberly Malphrus, Melissa Murray, Todd E. Golde, Nathan D.
    Acta Neuropathologica.2016; 132(2): 197.     CrossRef
  • Current status of biomarker research in neurology
    Jiri Polivka, Jiri Polivka, Kristyna Krakorova, Marek Peterka, Ondrej Topolcan
    EPMA Journal.2016;[Epub]     CrossRef
  • Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies
    Irene López González, Paula Garcia-Esparcia, Franc Llorens, Isidre Ferrer
    International Journal of Molecular Sciences.2016; 17(2): 206.     CrossRef
  • Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories
    Pawel Tacik, Monica Sanchez-Contreras, Rosa Rademakers, Dennis W. Dickson, Zbigniew K. Wszolek
    Neurodegenerative Diseases.2016; 16(1-2): 12.     CrossRef
Original Article
Gender Differences in Age-Related Striatal Dopamine Depletion in Parkinson’s Disease
Jae Jung Lee, Jee Hyun Ham, Phil Hyu Lee, Young H. Sohn
J Mov Disord. 2015;8(3):130-135.   Published online September 10, 2015
DOI: https://doi.org/10.14802/jmd.15031
  • 20,910 View
  • 111 Download
  • 24 Citations
AbstractAbstract PDFSupplementary Material
Objective Gender differences are a well-known clinical characteristic of Parkinson’s disease (PD). In-vivo imaging studies demonstrated that women have greater striatal dopamine transporter (DAT) activity than do men, both in the normal population and in PD patients. We hypothesize that women exhibit more rapid aging-related striatal DAT reduction than do men, as the potential neuroprotective effect of estrogen wanes with age.
Methods This study included 307 de novo PD patients (152 men and 155 women) who underwent DAT scans for an initial diagnostic work-up. Gender differences in age-related DAT decline were assessed in striatal sub-regions using linear regression analysis.
Results Female patients exhibited greater DAT activity compared with male patients in all striatal sub-regions. The linear regression analysis revealed that age-related DAT decline was greater in the anterior and posterior caudate, and the anterior putamen in women compared with men; we did not observe this difference in other sub-regions.
Conclusions This study demonstrated the presence of gender differences in age-related DAT decline in striatal sub-regions, particularly in the antero-dorsal striatum, in patients with PD, presumably due to aging-related decrease in estrogen. Because this difference was not observed in the sensorimotor striatum, this finding also suggests that women may not have a greater capacity to tolerate PD pathogenesis than do men.

Citations

Citations to this article as recorded by  
  • Worldwide trends in mortality related to Parkinson's disease in the period of 1994–2019: Analysis of vital registration data from the WHO Mortality Database
    Ioannis C. Lampropoulos, Foteini Malli, Olga Sinani, Konstantinos I. Gourgoulianis, Georgia Xiromerisiou
    Frontiers in Neurology.2022;[Epub]     CrossRef
  • Sex differences in Parkinson's Disease: An emerging health question
    Luiz Philipe de Souza Ferreira, Rafael André da Silva, Matheus Marques Mesquita da Costa, Vinicius Moraes de Paiva Roda, Santiago Vizcaino, Nilma R.L.L. Janisset, Renata Ramos Vieira, José Marcos Sanches, José Maria Soares Junior, Manuel de Jesus Simões
    Clinics.2022; 77: 100121.     CrossRef
  • Parkinson's disease in women: Mechanisms underlying sex differences
    Bhupesh Vaidya, Kritika Dhamija, Priyanka Guru, Shyam Sunder Sharma
    European Journal of Pharmacology.2021; 895: 173862.     CrossRef
  • Temporalis Muscle Thickness as an Indicator of Sarcopenia Is Associated With Long-term Motor Outcomes in Parkinson’s Disease
    Seok Jong Chung, Yun Joong Kim, Han Soo Yoo, Jin Ho Jung, KyoungWon Baik, Hye Sun Lee, Yang Hyun Lee, Ji-Man Hong, Young H Sohn, Phil Hyu Lee, Jay Magaziner
    The Journals of Gerontology: Series A.2021; 76(12): 2242.     CrossRef
  • Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review
    Giovanni Palermo, Sara Giannoni, Gabriele Bellini, Gabriele Siciliano, Roberto Ceravolo
    International Journal of Molecular Sciences.2021; 22(20): 11234.     CrossRef
  • Sex‐specific association of urate and levodopa‐induced dyskinesia in Parkinson’s disease
    J. H. Jung, S. J. Chung, H. S. Yoo, Y. H. Lee, K. Baik, B. S. Ye, Y. H. Sohn, P. H. Lee
    European Journal of Neurology.2020; 27(10): 1948.     CrossRef
  • Sex differences in primary delusional infestatation: An insight into etiology and potential novel therapy
    Stephanie Y. Chan, John Koo
    International Journal of Women's Dermatology.2020; 6(3): 226.     CrossRef
  • Joint Multi-modal Parcellation of the Human Striatum: Functions and Clinical Relevance
    Xiaojin Liu, Simon B. Eickhoff, Felix Hoffstaedter, Sarah Genon, Svenja Caspers, Kathrin Reetz, Imis Dogan, Claudia R. Eickhoff, Ji Chen, Julian Caspers, Niels Reuter, Christian Mathys, André Aleman, Renaud Jardri, Valentin Riedl, Iris E. Sommer, Kaustubh
    Neuroscience Bulletin.2020; 36(10): 1123.     CrossRef
  • Predictors of Pharyngeal Dysphagia in Patients with Parkinson’s Disease
    Inga Claus, Paul Muhle, Judith Suttrup, Bendix Labeit, Sonja Suntrup-Krueger, Rainer Dziewas, Tobias Warnecke
    Journal of Parkinson's Disease.2020; : 1.     CrossRef
  • Emerging Concepts of Motor Reserve in Parkinson’s Disease
    Seok Jong Chung, Jae Jung Lee, Phil Hyu Lee, Young H. Sohn
    Journal of Movement Disorders.2020; 13(3): 171.     CrossRef
  • Lack of consistent sex differences in d-amphetamine-induced dopamine release measured with [18F]fallypride PET
    Christopher T. Smith, Linh C. Dang, Leah L. Burgess, Scott F. Perkins, M. Danica San Juan, Darcy K. Smith, Ronald L. Cowan, Nam T. Le, Robert M. Kessler, Gregory R. Samanez-Larkin, David H. Zald
    Psychopharmacology.2019; 236(2): 581.     CrossRef
  • Predictive clinical factors for penetration and aspiration in Parkinson's disease
    Julie Cläre Nienstedt, Moritz Bihler, Almut Niessen, Rosemarie Plaetke, Monika Pötter‐Nerger, Christian Gerloff, Carsten Buhmann, Christina Pflug
    Neurogastroenterology & Motility.2019; 31(3): e13524.     CrossRef
  • Does the Side Onset of Parkinson’s Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?
    Seok Jong Chung, Han Soo Yoo, Hye Sun Lee, Phil Hyu Lee, Young H. Sohn
    Journal of Parkinson's Disease.2019; 9(1): 241.     CrossRef
  • Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
    Yang Hyun Lee, Jungho Cha, Seok Jong Chung, Han Soo Yoo, Young H. Sohn, Byoung Seok Ye, Phil Hyu Lee
    Scientific Reports.2019;[Epub]     CrossRef
  • The sex-specific interaction of the microbiome in neurodegenerative diseases
    Laura M. Cox, Hadi Abou-El-Hassan, Amir Hadi Maghzi, Julia Vincentini, Howard L. Weiner
    Brain Research.2019; 1724: 146385.     CrossRef
  • Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D 2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18 F-MNI-659 and 11 C-raclopride with correction for partial volume effect
    Patrik Fazio, Martin Schain, Ladislav Mrzljak, Nahid Amini, Sangram Nag, Nabil Al-Tawil, Cheryl J. Fitzer-Attas, Juliana Bronzova, Bernhard Landwehrmeyer, Cristina Sampaio, Christer Halldin, Andrea Varrone
    NeuroImage.2017; 152: 330.     CrossRef
  • Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells
    Barbara Pavan, Antonio Capuzzo, Alessandro Dalpiaz
    Drug Discovery Today.2017; 22(7): 1123.     CrossRef
  • Gender differences in Parkinson's disease: A clinical perspective
    D. Georgiev, K. Hamberg, M. Hariz, L. Forsgren, G.-M. Hariz
    Acta Neurologica Scandinavica.2017; 136(6): 570.     CrossRef
  • The relationship between subcortical brain volume and striatal dopamine D2/3receptor availability in healthy humans assessed with [11C]-raclopride and [11C]-(+)-PHNO PET
    Fernando Caravaggio, Jun Ku Chung, Eric Plitman, Isabelle Boileau, Philip Gerretsen, Julia Kim, Yusuke Iwata, Raihaan Patel, M. Mallar Chakravarty, Gary Remington, Ariel Graff-Guerrero
    Human Brain Mapping.2017; 38(11): 5519.     CrossRef
  • Single nucleotide polymorphisms in the toll-like receptor 2 (TLR2) gene are associated with sporadic Parkinson’s disease in the North-eastern Han Chinese population
    Xiaoyuan Li, Li Xue, Jinfang Sun, Yanping Sun, Anmu Xie
    Neuroscience Letters.2017; 656: 72.     CrossRef
  • Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females
    Fernando Caravaggio, Eric Plitman, Jun Ku Chung, Philip Gerretsen, Julia Kim, Yusuke Iwata, Mallar Chakravarty, Gary Remington, Ariel Graff-Guerrero
    European Journal of Neuroscience.2017; 46(7): 2253.     CrossRef
  • Does smoking impact dopamine neuronal loss in de novo Parkinson disease?
    Yoonju Lee, Jungsu S. Oh, Seok Jong Chung, Su Jin Chung, Soo-Jong Kim, Chung Mo Nam, Phil Hyu Lee, Jae Seung Kim, Young H. Sohn
    Annals of Neurology.2017; 82(5): 850.     CrossRef
  • The analysis of relationship between selected sociodemografic factors and disorders of speech organs in Parkinson`s patients
    Wioletta Pawlukowska, Karolina Skonieczna-Żydecka, Iwona Rotter, Krystyna Honczarenko, Przemysław Nowacki
    BMC Neurology.2017;[Epub]     CrossRef
  • Dose‐Response Analysis of the Effect of Carbidopa‐Levodopa Extended‐Release Capsules (IPX066) in Levodopa‐Naive Patients With Parkinson Disease
    Zhongping Lily Mao, Nishit B. Modi
    The Journal of Clinical Pharmacology.2016; 56(8): 974.     CrossRef
Case Report
Creutzfeldt-Jakob Disease in a Tertiary Care Hospital in Thailand: A Case Series and Review of the Literature
Praween Lolekha, Ahmed Rasheed, Chutanat Yotsarawat
J Mov Disord. 2015;8(3):136-140.   Published online September 10, 2015
DOI: https://doi.org/10.14802/jmd.15014
  • 16,931 View
  • 78 Download
  • 4 Citations
AbstractAbstract PDF
Creutzfeldt-Jakob Disease (CJD) is an incurable and inevitably fatal neurodegenerative disorder. Although CJD has a worldwide distribution, there are no official statistics on CJD in Thailand. A diagnosis of CJD is suspected when a patient develops rapidly progressive dementia with myoclonus. However, CJD may be mistaken for a variety of illnesses because its initial presentation frequently consists of non-specific symptoms. Here, we examined cases of sporadic CJD (sCJD) from Thammasat University Hospital (a tertiary care hospital in Thailand) between January 1, 2012 and December 31, 2014. Three cases of probable and possible sCJD were collected. All cases presented with rapidly progressive cognitive dysfunction accompanied by spontaneous myoclonus. Classical electroencehalography changes and typical abnormal MRI features were observed. All of the cases died within a period of 8 months. None of the patients underwent brain biopsy. Our findings raise questions about the prevalence of CJD in Thailand, which needs further study.

Citations

Citations to this article as recorded by  
  • The importance of ongoing international surveillance for Creutzfeldt–Jakob disease
    Neil Watson, Jean-Philippe Brandel, Alison Green, Peter Hermann, Anna Ladogana, Terri Lindsay, Janet Mackenzie, Maurizio Pocchiari, Colin Smith, Inga Zerr, Suvankar Pal
    Nature Reviews Neurology.2021; 17(6): 362.     CrossRef
  • Case series of Creutzfeldt-Jakob disease in a third-level hospital in Quito
    Germaine Eleanor Torres Herrán, Andrés Damián Ortega Herrera, Braulio Martinez Burbano, Marcos Serrano-Dueñas, María Angélica Ortiz Yepez, Raúl Alberto Barrera Madera, Luis Alfredo Masabanda Campaña, Guillermo David Baño Jiménez, Denny Maritza Santos Salt
    BMC Neurology.2018;[Epub]     CrossRef
  • An Evaluation of Rapidly Progressive Dementia Culminating in a Diagnosis of Creutzfeldt–Jakob Disease
    Parmvir Parmar, Curtis L. Cooper, Daniel Kobewka
    Case Reports in Infectious Diseases.2018; 2018: 1.     CrossRef
  • Diffusion-weighted MRI abnormalities antedate the onset of sporadic Creutzfeldt-Jakob disease
    Keisuke Suzuki, Akiko Kawasaki, Takahide Nagashima, Koichi Hirata
    Neurology.2016; 87(8): 843.     CrossRef
Letters to the editor
Dural Arteriovenous Fistula-Associated Reversible Parkinsonism with Presynaptic Dopaminergic Loss
Hang Rai Kim, Jee-Young Lee, Yu Kyeong Kim, Hyeyoung Park, Han-Joon Kim, Young-Je Son, Beom Seok Jeon
J Mov Disord. 2015;8(3):141-143.   Published online September 10, 2015
DOI: https://doi.org/10.14802/jmd.15021
  • 12,501 View
  • 61 Download
  • 4 Citations
PDF

Citations

Citations to this article as recorded by  
  • The Sudden Onset of Pure Parkinsonism Caused by Intracranial Dural Arteriovenous Fistulas
    Hitoshi Kawasaki, Risa Okuda, Ryu Yokoyama, Toshimasa Yamamoto
    Internal Medicine.2022; 61(7): 1059.     CrossRef
  • Reversible Parkinsonism and Rapidly Progressive Dementia Due to Dural Arteriovenous Fistula: Case Series and Literature Review
    Joshua Lai, Manraj K.S. Heran, A. Jon Stoessl, Peter A. Gooderham
    Movement Disorders Clinical Practice.2017; 4(4): 607.     CrossRef
  • Dementia and Parkinsonism-a Rare Presentation of Intracranial Dural Arteriovenous Fistulae
    Manoj Gopinath, Chinmay Nagesh, K Santhosh, ER Jayadevan
    Neurointervention.2017; 12(2): 125.     CrossRef
  • Straight sinus dural arteriovenous fistula presenting with reversible parkinsonism
    Jiali Pu, Xiaoli Si, Rong Ye, Baorong Zhang
    Medicine.2017; 96(49): e9005.     CrossRef
Predominant Jaw Myoclonus from Cefepime Toxicity: A Case Report and a Review of the Literature
Sina Khasani, Sonia Gill, Liliya Semenova, Harini Sarva
J Mov Disord. 2015;8(3):144-146.   Published online September 10, 2015
DOI: https://doi.org/10.14802/jmd.15017
  • 10,825 View
  • 45 Download
  • 1 Citations
PDF

Citations

Citations to this article as recorded by  
  • Metronidazole-Induced Craniocervical Myoclonus with Reversible Bilateral Dentate Nucleus Lesions
    Hyun Chang Lee, Young Eun Kim, Hyeo-Il Ma
    Journal of Movement Disorders.2017; 10(1): 67.     CrossRef
Retraction

JMD : Journal of Movement Disorders